Ovarian surface epithelium, ovulation and carcinogenesis

Biological Reviews

Volumn 71, Issue 4, 1996, Pages 529-543

  Murdoch, William James ^a  

^a UNIVERSITY OF WYOMING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALTRETAMINE; BUTHIONINE SULFOXIMINE; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; GESTAGEN; HYDROXYUREA; IFOSFAMIDE; MELPHALAN; PACLITAXEL; PROSTAGLANDIN; TAMOXIFEN;

ADJUVANT CHEMOTHERAPY; BLOOD TOXICITY; CARCINOGENESIS; EPITHELIUM; FEMALE; HUMAN; HYPERSENSITIVITY; NAUSEA; NEPHROTOXICITY; NEUROTOXICITY; OVARY; OVARY CANCER; OVULATION; REVIEW; VOMITING;

ANIMALS; EPITHELIAL CELLS; EPITHELIUM; FEMALE; HUMANS; OVARIAN NEOPLASMS; OVARY; OVULATION;

EID: 0029972151     PISSN: 14647931     EISSN: 1469185X     Source Type: Journal    
DOI: 10.1111/j.1469-185X.1996.tb01283.x     Document Type: Article

References (128)

1. Acien, P. (1992). Embryological observations on the female genital tract. Human Reproduction 7, 437-445.
2. Ackerman, R. C. & Murdoch, W. J. (1993). Prostaglandin-induced apoptosis of ovarian surface epithelial cells. Prostaglandins 45, 475-485.
3. Ackerman, R. C., Johnson, G. A., Van Kirk, E. A., Asirvatham, A. L. & Murdoch, W. J. (1994). Induction of apoptotic or lytic death in an ovarian adenocarcinoma cell line by antibodies generated against a synthetic N-terminal extracellular domain gonadotropin-releasing hormone receptor peptide. Cancer Letters 81, 177-184.
4. Amos, C. I. & Struewing, J. P. (1993). Genetic epidemiology of epithelial ovarian cancer. Cancer 71, 566-572.
5. Anderson, E., Lee, G., Letourneau, R., Albertini, D. F. & Meller, S. M. (1976). Cytological observations of the ovarian epithelium in mammals during the reproductive cycle. Journal of Morphology 150, 135-166.
6. Auersperg, N., MacLaren, I. A. & Kruk, P. A. (1991). Ovarian surface epithelium: Autonomous production of connective tissue-type extracellular matrix. Biology of Reproduction 44, 717-724.
7. Baker, T. R. & Piver, M. S. (1994). Etiology, biology, and epidemiology of ovarian cancer. Seminars in Surgical Oncology 10, 242-248.
8. Balasch, J. & Barri, P. N. (1993). Follicular stimulation and ovarian cancer? Human Reproduction 8, 990-996.
9. Barber, H. R. K. (1993). Prophylaxis in ovarian cancer. Cancer 71, 1529-1533.
10. Barr, P. J. & Tomei, L. D. (1994). Apoptosis and its role in human disease. Biotechnology 12, 487-493.
11. Barton, D. P. J., Blanchard, D. K., Wells, A. F., Nicosia, S. V., Roberts, W. S., Cavanagh, D. & Djeu, J. Y. (1994). Expression of interleukin-2 receptor alpha (IL-2Rα) mRNA and protein in advanced epithelial ovarian cancer. Anticancer Research 14, 761-772.
12. Bast, R. C. (1993). Perspectives on the future of cancer markers. Clinical Chemistry 39, 2444-2451.
13. Bast, R. C., Boyer, C. M., Jacobs, I., Xu, F. J., Wu, S., Wiener, J. & Kohler, M. (1993). Cell growth regulation in epithelial ovarian cancer. Cancer 71, 1597-1601.
14. Berchuck, A., Kohler, M. F., Boente, M. P., Rodriguez, G. C., Whitaker, R. S. & Bast, R. C. (1993). Growth regulation and transformation of ovarian epithelium. Cancer 71, 545-551.
15. Berkova, N. & Page, M. (1995). Addition of hTNFα potentiates cytotoxicity of taxol in human ovarian cancer lines. Anticancer Research 15, 863-866.
16. Bjersing, L. & Cajander, S. (1974a). Ovulation and the mechanism of follicle rupture. I. Light microscopic changes in rabbit ovarian follicles prior to induced ovulation. Cell and Tissue Research 149, 287-300.
17. Bjersing, L. & Cajander, S. (1974b). Ovulation and the mechanism of follicle rupture. II. Scanning electron microscopy of rabbit germinal epithelium prior to induced ovulation. Cell and Tissue Research 149, 301-312.
18. Bjersing, L. & Cajander, S. (1974c). Ovulation and the mechanism of follicle rupture. III. Transmission electron microscopy of rabbit germinal epithelium prior to induced ovulation. Cell and Tissue Research 149, 313-327.
19. Bjersing, L. & Cajander, S. (1974d). Ovulation and the mechanism of follicle rupture. V. Ultrastructure of tunica albuginea and theca externa of rabbit Graafian follicles prior to induced ovulation. Cell and Tissue Research 153, 15-30.
20. Bjersing, L. & Cajander, S. (1975). Ovulation and the role of the ovarian surface epithelium. Experientia 31, 605-608.
21. v genotype. Biology of Reproduction 53, 775-779.
22. Blandau, R. J. (1967). Anatomy of ovulation. Clinical Obstetrics and Gynecology 10, 347-360.
23. Blaustein, A. & Lee, H. (1979). Surface cells of the ovary and pelvic peritoneum: A histochemical and ultrastructural comparison. Gynecologic Oncology 8, 34-43.
24. Brinkman, U. & Pastan, I. (1994). Immunotoxins against cancer. Biochimica et Biophysica Acta 1198, 27-45.
25. Byskov, A. G. (1969). Ultrastructural studies on the preovulatory follicle in the mouse ovary. Z Zellforsch Mikroskopisch Anatomische 100, 285-299.
26. Byskov, A. G. (1986). Differentiation of mammalian embryonic gonad. Physiological Reviews 66, 71-117.
27. Cajander, S. (1976). Structural alterations of rabbit ovarian follicles after mating with special reference to the overlying surface epithelium. Cell and Tissue Research 173, 437-449.
28. Cavender, J. C. & Murdoch, W. J. (1988). Morphological studies of the microcirculatory system of periovulatory ovine follicles. Biology of Reproduction 39, 989-997.
29. Cramer, D. W. & Welch, W. R. (1983). Determinants of ovarian cancer risk. II. Inferences regarding pathogenesis. Journal of the National Cancer Institute 71, 717-721.
30. Davol, P., Beitz, J. G., Mohler, M., Ying, W., Cook, J., Lappi, D. A. & Frackelton, A. R. (1995). Saporin toxins directed to basic fibroblast growth factor receptors effectively target human ovarian teratocarcinoma in an animal model. Cancer 76, 79-85.
31. Devine, P. L., McGuckin, M. A. & Ward, B. G. (1992). Circulating mucins as tumor markers in ovarian cancer. Anticancer Research 12, 709-718.
32. Downs, S. & Longo, F. (1983). An ultrastructural study of preovulatory apical development in mouse ovarian follicles: Effects of indomethacin. Anatomical Record 205, 159-168.
33. DiRenzo, M. F., Olivero, M., Katsaros, D., Crepaldi, T., Gaglia, P., Zola, P., Sismondi, P. & Comoglio, P. M. (1994). Overexpression of the met/HGF receptor in ovarian cancer. International Journal of Cancer 58, 658-662.
34. Droegemueller, W. (1994). Screening for ovarian carcinoma: Hopeful and wishful thinking. American Journal of Obstetrics and Gynecology 170, 1095-1098.
35. Eccles, D. M., Cranston, G., Steele, C. M., Nakamura, Y. & Leonard, R. C. F. (1990). Allele loss on chromosome 17 in human epithelial ovarian carcinoma. Oncogene 5, 1599-1601.
36. Emons, G., Ortmann, O., Pahwa, G. S., Hackenberg, R., Oberheuser, F. & Schulz, K. D. (1992). Intracellular actions of gonadotropic and peptide hormones and the therapeutic value of GnRH-agonists in ovarian cancer. Acta Obstetrica et Gynecologica Scandinavia Supplement 155, 31-38.
37. Emons, G. & Schally, A. V. (1994). The use of luteinizing hormone releasing hormone agonists and antagonists in gynaecological cancers. Human Reproduction 9, 1364-1379.
38. Espey, L. L. (1967). Ultrastructure of the apex of the rabbit Graafian follicle during the ovulatory process. Endocrinology 81, 267-276.
39. Fathalla, M. F. (1971). Incessant ovulation - a factor in ovarian neoplasia?. Lancet 2, 163.
40. Fleischer, A. C. & Jones, H. W. (1993). Early Detection of Ovarian Carcinoma with Transvaginal Sonography. Potentials and Limitations. Raven Press, New York.
41. Fredrickson, T. N. (1987). Ovarian tumors of the hen. Environmental Health Perspectives 73, 35-51.
42. Freedman, R. S., Ioannides, C. G., Mathioudakis, G. & Platsoucas, C. D. (1992). Novel immunologic strategies in ovarian carcinoma. American Journal of Obstetrics and Gynecology 167, 1470-1478.
43. Gallion, H. H. & Bast, R. C. (1993). National cancer institute conference on investigational strategies for detection and intervention in early ovarian cancer. Cancer Research 53, 3839-3842.
44. Gillett, W. R. (1991). Artefactual loss of human ovarian surface epithelium: Potential clinical significance. Reproduction, Fertility and Development 3, 93-98.
45. Gillett, W. R., Mitchell, A. & Hurst, P. R. (1991). A scanning electron microscopic study of the human ovarian surface: Characterization of two cell types. Human Reproduction 6, 645-650.
46. Godwin, A. K., Miller, P. D., Getts, L. A., Jackson, K., Sonoda, G., Schray, K. J., Testa, J. R. & Hamilton, T. C. (1995). Retroviral-like sequences specifically expressed in the rat ovary detect genetic differences between normal and transformed rat ovarian surface epithelial cells. Endocrinology 136, 4640-4649.
47. Godwin, A. K., Perez, R. P., Johnson, S. W., Hamaguchi, K. & Hamilton, T. C. (1992a). Growth regulation of ovarian cancer. Hematology/Oncology Clinics of North America 6, 829-841.
48. Godwin, A. K., Testa, J. R. & Hamilton, T. C. (1993). The biology of ovarian cancer development. Cancer 71, 530-536.
49. Godwin, A. K., Testa, J. R., Handel, L. M., Liu, Z., Vanderveer, L. A., Tracey, P. A. & Hamilton, T. C. (1992b). Spontaneous transformation of rat ovarian surface epithelial cells: Association with cytogenetic changes and implications of repeated ovulation in the etiology of ovarian cancer. Journal of the National Cancer Institute 84, 592-601.
50. Godwin, A. K., Vanderveer, L., Schultz, D., Lynch, H., Altomare, D., Buetow, K., Daly, M., Getts, L. A., Masny, A., Rosenblum, N., Hogan, M., Ozols, R. F. & Hamilton, T. C. (1994). A common region of deletion on chromosome 17q in both sporadic and familial ovarian tumors distal to BRCAi. American Journal of Human Genetics 55, 666-677.
51. Gondos, B. (1975). Surface epithelium of the developing ovary. American Journal of Pathology 81, 303-320.
52. Granai, C. O., Gajewski, W. H. & Arena, B. (1994). Ovarian cancer: Issues and management. Cancer Journal 7, 7-11.
53. Hafez, E. S. E., Makabe, S. & Motta, P. M. (1980). Surface ultrastructure of functional and nonfunctional ovaries. International Journal of Fertility 25, 94-99.
54. Hafez, E. S. E. & Makabe, S. (1982). Scanning electron microscopy of nonfunctional human ovaries. Journal of Reproductive Medicine 27, 271-274.
55. Hamilton, T. C. (1992). Ovarian cancer, biology. Current Problems in Cancer 16, 5-57.
56. Hoskins, W. J. (1993). Surgical staging and cytoreductive surgery of epithelial ovarian cancer. Cancer 71, 1534-1540.
57. Irmer, G., Burger, C., Muller, R., Ortmann, O., Peter, U., Kakar, S. S., Neill, J. D., Schulz, K. D. & Emons, G. (1995). Expression of the messenger RNAs for luteinizing hormone-releasing hormone (LHRH) and its receptor in human ovarian epithelial carcinoma. Cancer Research 55, 817-822.
58. Jindal, S. K., Ishii, E., Letarte, M., Vera, S., Teerds, K. J. & Dorrington, J. H. (1995). Regulation of transforming growth factor α gene expression in an ovarian surface epithelial cell line derived from a human carcinoma. Biology of Reproduction 52, 1027-1037.
59. 2α induces release of lysosomal hydrolase from luteinized rat ovarian slices. Prostaglandins 10, 685-692.
60. Kikuchi, Y., Kita, T., Hirata, J. & Fukushima, M. (1994). Preclinical studies of antitumor prostaglandins by using human ovarian cancer cells. Cancer and Metastasis Review 13, 309-315.
61. Kohler, M. F., Kerns, B. M., Humphrey, P. A., Marks, J. R., Bast, R. C. & Berchuck, A. (1993). Mutation and overexpression of p53 in early-stage epithelial ovarian cancer. Obstetrics and Gynecology 81, 643-650.
62. Kruk, P. A. & Auersperg, N. (1992). Human ovarian surface epithelial cells are capable of physically restructuring extracellular matrix. American Journal of Obstetrics and Gynecology 167, 1437-1443.
63. Kurachi, H., Morishige, K., Adachi, H., Adachi, K., Tasaka, K., Sawada, M. & Miyake, A. (1994). Implantation and growth of epidermal growth factor (EGF) receptor expressing human ovarian cancer xenografts in nude mice is dependent on EGF. Cancer 74, 2984-2990.
64. Lauchlan, S. C. (1972). The secondary Mullerian system. Obstetrical and Gynecological Survey 27, 133-146.
65. Lee, M. M. & Donahoe, P. K. (1993). Mullerian inhibiting substance: A gonadal hormone with multiple functions. Endocrine Reviews 14, 152-164.
66. Levesque, M. A., Katsaros, D., Yu, H., Zola, P., Sismondi, P., Giardina, G. & Diamandis, E. P. (1995). Mutant p53 protein overexpression is associated with poor outcome in patients with well or moderately differentiated ovarian carcinoma. Cancer 75, 1327-1338.
67. Look, K. Y. (1994). Evolution of screening for epithelial ovarian carcinoma: The quest for early diagnosis. Seminars in Surgical Oncology 10, 261-267.
68. Lowry, S., Russell, H., Hickey, I. & Atkinson, R. (1991). Incessant ovulation and ovarian cancer. Lancet 337, 1544-1545.
69. Magliocco, A. & Brilliant, M. (1994). Genome scanning detects genetic alterations in human ovarian carcinoma. Human Mutation 4, 141-149.
70. Malik, S. & Balkwill, F. (1991). Epithelial ovarian cancer: A cytokine propelled disease. British Journal of Cancer 64, 617-620.
71. Manetta, A., Gamboa-Vujicic, G., Paredes, P., Emma, D., Laio, S., Leong, L., Asch, B. & Schally, A. V. (1995). Inhibition of growth of human ovarian cancer in nude mice by luteinizing hormone-releasing hormone antagonist Cetrorelix (SB-75*). Fertility and Sterility 63, 282-287.
72. Mant, J. W. F. & Vessey, M. P. (1994). Ovarian and endometrial cancers. Cancery Surveys 19, 287-307.
73. Markman, M. & Hoskins, W. J. (1993). Cancer of the Ovary. Raven Press, New York.
74. Markman, M., Reichman, B., Hakes, T., Curtin, J., Jones, W., Lewis, J. L., Barakat, R., Rubin, S., Mychalczak, B., Saigo, P., Almadrones, L. & Hoskins, W. (1993). Intraperitoneal chemotherapy in the management of ovarian cancer. Cancer 71, 1565-1570.
75. Menczer, J., Modan, M., Ranon, L. & Golan, A. (1979). Possible role of mumps virus in the etiology of ovarian cancer. Cancer 43, 1375-1379.
76. Miki, Y., Swensen, J., Shattuck-Eidens, D., Futreal, P. A., Harshman, K., Tavtigian, S., Liu, Q., Cochran, C., Bennett, L. M., Ding, W., Bell, R., Rosenthal, J., Hussey, C., Tran, T., McClure, M., Frye, C., Hattier, T., Phelps, R., Haugen-Strano, A., Katcher, H., Yakumo, K., Gholami, Z., Shaffer, D., Stone, S., Bayer, S., Wray, C., Bogden, R., Dayananth, P., Ward, J., Tonin, P., Narod, S., Bristow, P. K., Norris, F. H., Helvering, L., Morrison, P., Rosteck, P., Lai, M., Barrett, J. C., Lewis, C., Neuhausen, S., Cannon-Albright, L., Goldgar, D., Wiseman, R., Kamb, A. & Skolnick, M. H. (1994). A strong candidate for the breast and ovarian cancer susceptibility gene BRCAi. Science 266, 66-71.
77. Mossman, H. W. & Duke, K. L. (1973). Comparative Morphology of the Mammalian Ovary. University of Wisconsin Press, Madison.
78. Motta, P., Cherney, D. D. & Didio, L. J. A. (1971). Scanning and transmission electron microscopy of the ovarian surface in mammals with special references to ovulation. Journal of Submicroscopic Cytology 3, 85-100.
79. Motta, P. & van Blerkom, J. (1975). A scanning electron microscopic study of the luteo-follicular complex. II. Events leading to ovulation. American Journal of Anatomy 143, 241-263.
80. Motta, P. M., van Blerkom, J. & Makabe, S. (1980). Changes in the surface morphology of ovarian “germinal” epithelium during the reproductive cycle and in some pathological conditions. Journal of Submicroscopic Cytology 12, 407-425.
81. Murdoch, W. J. (1994). Ovarian surface epithelium during ovulatory and anovulatory ovine estrous cycles. Anatomical Record 240, 322-326.
82. Murdoch, W. J. (1995). Programmed cell death in preovulatory ovine follicles. Biology of Reproduction 53, 8-12.
83. Murdoch, W. J., Hansen, T. R. & McPherson, L. A. (1993). Role of eicosanoids in vertebrate ovulation. Prostaglandins 46, 85-115.
84. Murdoch, W. J., Slaughter, R. G. & Ji, T. H. (1991). In situ hybridization analysis of ovarian prostaglandin endoperoxide synthase mRNA throughout the periovulatory period of the ewe. Domestic Animal Endocrinology 8, 455-457.
85. Nelson, H. (1991). Targeted cellular immunotherapy with bifunctional antibodies. Cancer Cells 3, 163-172.
86. Nguyen, H. H., Averette, H. E. & Janicek, M. (1994). Ovarian carcinoma: A review of the significance of familial risk factors and the role of prophylactic oophorectomy in cancer prevention. Cancer 74, 545-55.
87. Nilsson, O. & Munshi, S. R. (1973). Scanning electron microscopy of mouse follicles at ovulation. Journal of Submicroscopic Cytology 5, 1-6.
88. Oram, D. H. & Jeyarajah, A. R. (1994). The role of ultrasound and tumour markers in the early detection of ovarian cancer. British Journal of Obstetrics and Gynaecology 101, 939-945.
89. Osterholzer, H. O., Johnson, J. H. & Nicosia, S. V. (1985). An autoradiographic study of the rabbit ovarian surface epithelium before and after ovulation. Biology of Reproduction 33, 729-738.
90. Ozols, R. F. (1992). Ovarian cancer, treatment. Current Problems in Cancer 16, 67-125.
91. Papadaki, L. & Beilby, J. O. W. (1971). The fine structure of the surface epithelium of the human ovary. Journal of Cell Science 8, 445-465.
92. Parazzini, F., Franceschi, S., La Vecchia, C. & Fasoli, M. (1991). The epidemiology of ovarian cancer. Gynecologic Oncology 43, 9-23.
93. Parr, E. L. (1975). Rupture of ovarian follicles at ovulation. Journal of Reproduction and Fertility Supplement 22, 1-22.
94. Pendergrass, P. B. & Reber, M. (1980). Scanning electron microscopy of the Graafian follicle during ovulation in the golden hamster. Journal of Reproduction and Fertility 59, 21-24.
95. Perez, R. P., Godwin, A. K., Hamilton, T. C. & Ozols, R. F. (1991). Ovarian cancer biology. Seminars in Oncology 18, 186-204.
96. Peterson, C. M., Reed, R., Jolles, C. J., Jones, K. P., Straight, R. C. & Poulson, A. M. (1992). Photodynamic therapy of human ovarian epithelial carcinoma, OVCAR-3, heterotransplanted in the nude mouse. American Journal of Obstetrics and Gynecology 167, 1852-1855.
97. Peterson, C. M., Jolles, C. J., Carrell, D. T., Straight, R. C., Jones, K. P., Poulson, A. M. & Hatasaka, H. H. (1994). GnRH agonist therapy in human epithelial carcinoma (OVCAR-3) heterotransplanted in the nude mouse is characterized by latency and transience. Gynecologic Oncology 52, 26-30.
98. Pfisterer, J., Kommoss, F., Sauerbrei, W., Renz, H., du Bois, A., Kiechle-Schwarz, M. & Pfeiderer, A. (1994). Cellular DNA content and survival in advanced ovarian carcinoma. Cancer 74, 2509-2515.
99. Piver, M. S., Baker, T. R., Piedmonte, P. & Sandecki, A. M. (1991). Epidemiology and etiology of ovarian cancer. Seminars in Oncology 18, 177-185.
100. Podratz, K. C. & Kinney, W. K. (1993). Second-look operation in ovarian cancer. Cancer 71, 1551-1558.
101. Rao, B. R. & Slotman, B. J. (1991). Endocrine factors in common epithelial ovarian cancer. Endocrine Reviews 12, 14-26.
102. Rao, B. R., Slotman, B. J., Smirnova, Z. S. & Geldof, A. A. (1993). Hormones in ovarian cancer: Update 1993. Endocrine Reviews Monographs 1, 188-189.
103. Rawson, J. M. R. & Espey, L. L. (1977). Concentration of electron dense granules in the rabbit ovarian surface epithelium during ovulation. Biology of Reproduction 17, 561-566.
104. Resta, L., De Benedictis, G., Scordari, M. D., Orlando, E., Borraccino, V. & Milillo, F. (1987). Hyperplasia and metaplasia of ovarian surface epithelium. Tumori 73, 249-256.
105. Ribeiro, A. F., Ferronha, M. H. & David-Ferreira, J. F. (1983). Freeze-fracture study of the hamster ovary surface epithelium intercellular junctions. Journal of Submicroscopic Cytology 15, 415-423.
106. Risma, K. A., Clay, C. M., Nett, T. M., Wagner, T., Yun, J. & Nilson, J. H. (1995). Targeted overexpression of luteinizing hormone in transgenic mice leads to infertility, polycystic ovaries, and ovarian tumors. Proceedings of the National Academy of Sciences of the United States of America 92, 1322-1326.
107. Rodriguez, G. C., Boente, M. P., Berchuck, A., Whitaker, R. S., O’Briant, K. C., Xu, F. & Bast, R. C. (1993). The effect of antibodies and immunotoxins reactive with HER-2/neu on growth of ovarian and breast cancer cell lines. American Journal of Obstetrics and Gynecology 168, 228-232.
108. Rubin, S. C. (1993). Monoclonal antibodies in the management of ovarian cancer. Cancer 71, 1602-1612.
109. Runowicz, C. D., Wiernik, P. H., Einzig, A. I., Goldberg, G. L. & Horowitz, S. B. (1993). Taxol in ovarian cancer. Cancer 71, 1591-1596.
110. Russell, S. E. H., Hickey, G. I., Lowry, W. S., White, P. & Atkinson, R. J. (1990). Allele loss from chromosome 17 in ovarian cancer. Oncogene 5, 1581-1583.
111. Schwartzman, R. A. & Cidlowski, J. A. (1993). Apoptosis: The biochemistry and molecular biology of programmed cell death. Endocrine Reviews 14, 133-151.
112. Scott, J. S. (1984). How to induce ovarian cancer: And how not to. British Medical Journal 289, 781-782.
113. Shoham, Z. (1994). Epidemiology, etiology, and fertility drugs in ovarian epithelial carcinoma: Where are we today?. Fertility and Sterility 62, 433-448.
114. Shu, X. O., Gao, Y. T., Yuan, J. M., Ziegler, R. G. & Brinton, L. A. (1989). Dietary factors and epithelial ovarian cancer. British Journal Of Cancer 59, 92-96.
115. Spirtas, R., Kaufman, S. C. & Alexander, N. J. (1993). Fertility drugs and ovarian cancer: red alert or red herring?. Fertility and Sterility 59, 291-293.
116. Swairi-Itoh, M., Imai, A., Murase, T., Niwa, K., Itoh, N., Mori, H. & Tamaya, T. (1994). Different patterns of p53 gene mutations in endometrial carcinomas and endometroid carcinomas of the ovary. International Journal of Oncology 5, 583-588.
117. Talbot, P., Martin, G. G. & Ashby, H. (1987). Formation of the rupture site in preovulatory hamster and mouse follicles: loss of surface epithelium. Gamete Research 17, 287-302.
118. Talerman, A. (1992). Ovarian pathology. Current Opinion in Obstetrics and Gynecology 4, 608-615.
119. Tarlatzis, B. C., Grimbizis, G., Bontis, J. & Mantalenakis, S. (1995). Ovarian stimulation and ovarian tumours: A critical reappraisal. Human Reproduction Update 1, 284-301.
120. Tavassoli, F. A. (1994). Ovarian tumors with functioning manifestations. Endocrine Pathology 5, 137-148.
121. Thigpen, J. T., Vance, R. B. & Khansur, T. (1993). Second-line chemotherapy for recurrent carcinoma of the ovary. Cancer 71, 1559-1564.
122. Tsujimoto, D., Katayama, K., Tojo, S. & Mizoguti, H. (1982). Scanning electron microscopic studies on stigmas in rat ovaries. Acta Obstetrica et Gynecologica Scandinavia 61, 269-273.
123. van Nagell, J. R., DePriest, P. D., Gallion, H. H. & Pavlik, E. J. (1993). Ovarian cancer screening. Cancer 71, 1523-1528.
124. Vigne, J. L., Halburnt, L. L. & Skinner, M. K. (1994). Characterization of bovine ovarian surface epithelium and stromal cells: Identification of secreted proteins. Biology of Reproduction 51, 1213-1221.
125. Weakly, B. (1969). Differentiation of the surface epithelium of the hamster ovary. An electron microscopic study. Journal of Anatomy 105, 129-147.
126. Wischnitzer, S. (1965). The ultrastructure of the germinal epithelium of the mouse ovary. Journal of Morphology 117, 387-399.
127. Wu, S., Rodabaugh, K., Martinez-Maza, O., Watson, J. M., Silberstein, D. S., Boyer, C. M., Peters, W. P., Weinberg, J. B., Berek, J. S. & Bast, R. C. (1992). Stimulation of ovarian tumor cell proliferation with monocyte products including interleukin-1, interleukin-6, and tumor necrosis factor-α. American Journal of Obstetrics and Gynecology 166, 997-1007.
128. Ziltener, H. J., Maines-Bandiera, S., Schrader, J. W. & Auersperg, N. (1993). Secretion of bioactive interleukin-1, interleukin-6, and colony-stimulating factors by human surface epithelium. Biology of Reproduction 49, 635-641.